General
Preferred name
BISACODYL
Synonyms
Dulcolax ()
Brocalax ()
Fenilaxan ()
Feen-a-Mint Tablets ()
Biolax ()
Entrolax ()
Modane ()
NSC-755914 ()
Dulcodos ()
Theralax ()
SK-Bisacodyl ()
Correctol Tablets, Caplets ()
Evac-q-tabs ()
P&D ID
PD002452
CAS
603-50-9
Tags
natural product
drug
available
Approved by
FDA
First approval
2004
Drug Status
approved
Max Phase
Phase 4
Drug indication
Laxative
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
19
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Mechanistic Set
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
31
Properties
(calculated by RDKit )
Molecular Weight
361.13
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
3
cLogP
4.11
TPSA
65.49
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
6.0
QED
0.51
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Indication
constipation
MOA
laxative
Pathway
GPCR/G protein
Neuronal Signaling
Target
Dopamine Transporter
Opioid Receptor
Source data